Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy.
Klein, Fritz
Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy. [electronic resource] - Hepatitis research and treatment 2016 - 8325467 p. digital
Publication Type: Journal Article
2090-1364
10.1155/2016/8325467 doi
Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy. [electronic resource] - Hepatitis research and treatment 2016 - 8325467 p. digital
Publication Type: Journal Article
2090-1364
10.1155/2016/8325467 doi